Apte RS, Chen DS, Ferrara N (2019) VEGF in signaling and disease: beyond discovery and development. Cell 176(6):1248–1264

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bakhoum SF et al (2009) Genome stability is ensured by temporal control of kinetochore-microtubule dynamics. Nat Cell Biol 11(1):27–35

Article  CAS  PubMed  Google Scholar 

Battaglia RA et al (2018) Vimentin on the move: new developments in cell migration. F1000Research 7:1796

Article  Google Scholar 

Bruner HC, Derksen PWB (2018) Loss of E-cadherin-dependent cell-cell adhesion and the development and progression of cancer. Cold Spring Harb Perspect Biol 10(3):a029330

Article  PubMed  PubMed Central  Google Scholar 

Cao ZQ, Wang Z, Leng P (2019) Aberrant N-cadherin expression in cancer. Biomed Pharmacother 118:109320

Article  CAS  PubMed  Google Scholar 

Cao G et al (2022) How vascular smooth muscle cell phenotype switching contributes to vascular disease. Cell Commun Signal 20(1):180

Article  PubMed  PubMed Central  Google Scholar 

Chaffer CL et al (2016) EMT, cell plasticity and metastasis. Cancer Metastasis Rev 35(4):645–654

Article  PubMed  Google Scholar 

Chaw SY et al (2012) Epithelial to mesenchymal transition (EMT) biomarkers–E-cadherin, beta-catenin, APC and Vimentin–in oral squamous cell carcinogenesis and transformation. Oral Oncol 48(10):997–1006

Article  CAS  PubMed  Google Scholar 

Chen X et al (2022) Mutant p53 in cancer: from molecular mechanism to therapeutic modulation. Cell Death Dis 13(11):974

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cui Y et al (2015) Expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in Chinese patients with esophageal squamous cell carcinoma. J Cancer Res Ther 11(Suppl 1):C44–C48

CAS  PubMed  Google Scholar 

Deryugina EI, Quigley JP (2015) Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature. Matrix Biol 44–46:94–112

Article  PubMed  PubMed Central  Google Scholar 

Gao Z et al (2021) KIF2C promotes the proliferation of hepatocellular carcinoma cells in vitro and in vivo. Exp Ther Med 22(4):1094

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo J et al (2014) Cyclooxygenase-2 and vascular endothelial growth factor expressions are involved in ultrafiltration failure. J Surg Res 188(2):527-536.e2

Article  CAS  PubMed  Google Scholar 

Guo J et al (2023) KIF2C accelerates the development of non-small cell lung cancer and is suppressed by miR-186-3p via the AKT-GSK3beta-beta-catenin pathway. Sci Rep 13(1):7288

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ishikawa K et al (2008) Mitotic centromere-associated kinesin is a novel marker for prognosis and lymph node metastasis in colorectal cancer. Br J Cancer 98(11):1824–1829

Article  CAS  PubMed  PubMed Central  Google Scholar 

Krisanaprakornkit S, Iamaroon A (2012) Epithelial-mesenchymal transition in oral squamous cell carcinoma. ISRN Oncol 2012:681469

PubMed  PubMed Central  Google Scholar 

Levine AJ (2020) p53: 800 million years of evolution and 40 years of discovery. Nat Rev Cancer 20(8):471–480

Article  CAS  PubMed  Google Scholar 

Li X et al (2018) Application of liquid biopsy in bone and soft tissue sarcomas: present and future. Cancer Lett 439:66–77

Article  CAS  PubMed  Google Scholar 

Li RQ et al (2024) KIF2C: an important factor involved in signaling pathways, immune infiltration, and DNA damage repair in tumorigenesis. Biomed Pharmacother 171:116173

Article  CAS  PubMed  Google Scholar 

Louwen F, Yuan J (2013) Battle of the eternal rivals: restoring functional p53 and inhibiting Polo-like kinase 1 as cancer therapy. Oncotarget 4(7):958–971

Article  PubMed  PubMed Central  Google Scholar 

Manning AL et al (2007) The kinesin-13 proteins Kif2a, Kif2b, and Kif2c/MCAK have distinct roles during mitosis in human cells. Mol Biol Cell 18(8):2970–2979

Article  CAS  PubMed  PubMed Central  Google Scholar 

McKenzie L et al (2010) p53-dependent repression of polo-like kinase-1 (PLK1). Cell Cycle 9(20):4200–4212

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mittal V (2018) Epithelial mesenchymal transition in tumor metastasis. Annu Rev Pathol 13:395–412

Article  CAS  PubMed  Google Scholar 

Nakamura Y et al (2007) Clinicopathological and biological significance of mitotic centromere-associated kinesin overexpression in human gastric cancer. Br J Cancer 97(4):543–549

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ng JH et al (2017) Changing epidemiology of oral squamous cell carcinoma of the tongue: a global study. Head Neck 39(2):297–304

Article  PubMed  Google Scholar 

Nishio K et al (2016) Comparison of MMP2 and MMP9 expression levels between primary and metastatic regions of oral squamous cell carcinoma. J Oral Sci 58(1):59–65

Article  CAS  PubMed  Google Scholar 

Nusinow DP et al (2020) Quantitative proteomics of the cancer cell line Encyclopedia. Cell 180(2):387-402.e16

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pires I et al (2010) COX-1 and COX-2 expression in canine cutaneous, oral and ocular melanocytic tumours. J Comp Pathol 143(2–3):142–149

Article  CAS  PubMed  Google Scholar 

Pittayapruek P et al (2016) Role of matrix metalloproteinases in photoaging and photocarcinogenesis. Int J Mol Sci 17(6):868

Article  PubMed  PubMed Central  Google Scholar 

Ribatti D, Tamma R, Annese T (2020) Epithelial-mesenchymal transition in cancer: a historical overview. Transl Oncol 13(6):100773

Article  PubMed  PubMed Central  Google Scholar 

Sathiasekar AC et al (2017) Oral field cancerization and its clinical implications in the management in potentially malignant disorders. J Pharm Bioallied Sci 9(Suppl 1):S23–S25

PubMed  PubMed Central  Google Scholar 

Shakeel I et al (2021) Polo-like Kinase 1 as an emerging drug target: structure, function and therapeutic implications. J Drug Target 29(2):168–184

Article  CAS  PubMed  Google Scholar 

Shibata M et al (2005) Cyclo-oxygenase-1 and -2 expression in human oral mucosa, dysplasias and squamous cell carcinomas and their pathological significance. Oral Oncol 41(3):304–312